Search for Clinical Trial Results
Rubella - 19 Studies Found
| Status | Study |
| Completed |
Study Name: Rubella Susceptibility in Multiparous Women Condition:
Date: 2006-11-17 |
| Completed |
Study Name: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination Condition: Measles/Rubella Date: 2014-06-04 Interventions: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
| Completed |
Study Name: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination Condition: Measles/Rubella Date: 2014-05-28 Interventions: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
| Not yet recruiting |
Study Name: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella Condition:
Date: 2017-05-09 Interventions:
|
| Completed |
Study Name: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Condition:
Date: 2014-07-16 Interventions: Biological: Double viral (MR) vaccine Measles and Rubella vaccine, as single arm |
| Completed |
Study Name: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Condition: Measles; Mumps; Rubella Date: 2014-07-03 Interventions:
|
| Not yet recruiting |
Study Name: Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Condition:
|
| Completed |
Study Name: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations Condition:
Interventions: Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin |
| Completed |
Study Name: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Condition:
Interventions: |
| Completed |
Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Condition:
Interventions: |